Linked Life Data

15476206

Source:http://linkedlifedata.com/resource/pubmed/id/15476206

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-10-29
pubmed:abstractText
Antibodies to HLA are implicated in allograft rejection; as a consequence, tests to identify them are indicated in organ transplantation. Flow cytometry (FC) may improve the outcome of organ transplantation. Although increasingly used, most of the available FC techniques do not discriminate between complement and noncomplement-activating antibodies. However, the clinical relevance of noncomplement-activating antibodies is controversial. Therefore, many laboratories still use the conventional complement-dependent microlymphocytotoxicity crossmatch (CDC-XM) alone or in combination with FC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1552-4949
pubmed:author
pubmed:copyrightInfo
(c) 2004 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:volume
62
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
39-45
pubmed:dateRevised
2009-12-11
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Flow cytometric detection of complement-activating HLA antibodies.
pubmed:affiliation
Institute of Transfusion Medicine, Charité University Medicine, Berlin, Germany. constanze.schoenemann@charite.de <constanze.schoenemann@charite.de>
pubmed:publicationType
Journal Article, Evaluation Studies